Evidence map›Paper›PMID 26448642›Full record

ArticlePloS one2015

Sulf1 and Sulf2 Differentially Modulate Heparan Sulfate Proteoglycan Sulfation during Postnatal Cerebellum Development: Evidence for Neuroprotective and Neurite Outgrowth Promoting Functions.

Ina Kalus, Susanne Rohn, Tania M Puvirajesinghe, Scott E Guimond, Pieter J Eyckerman-Kölln, Gerdy Ten Dam, Toin H van Kuppevelt, Jeremy E Turnbull, Thomas Dierks

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Neural glycomics: the sweet side of nervous system functions.Cellular and molecular life sciences : CMLS · 2021
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Ina KalusFakultät für Chemie, Biochemie I, Universität Bielefeld, Bielefeld, Germany.
Susanne RohnFakultät für Chemie, Biochemie I, Universität Bielefeld, Bielefeld, Germany.
Tania M PuvirajesingheCentre for Glycobiology, School of Biological Sciences, University of Liverpool, Liverpool, United Kingdom.
Scott E GuimondCentre for Glycobiology, School of Biological Sciences, University of Liverpool, Liverpool, United Kingdom.
Pieter J Eyckerman-KöllnFakultät für Chemie, Biochemie I, Universität Bielefeld, Bielefeld, Germany.
Gerdy Ten DamDepartment of Biochemistry, University of Nijmegen, Nijmegen, The Netherlands, Center for Molecular Life Sciences, Radboud University Nijmegen Medical Center, Nijmegan, The Netherlands.
Toin H van KuppeveltDepartment of Biochemistry, University of Nijmegen, Nijmegen, The Netherlands, Center for Molecular Life Sciences, Radboud University Nijmegen Medical Center, Nijmegan, The Netherlands.
Jeremy E TurnbullCentre for Glycobiology, School of Biological Sciences, University of Liverpool, Liverpool, United Kingdom.
Thomas DierksFakultät für Chemie, Biochemie I, Universität Bielefeld, Bielefeld, Germany.
Bielefeld University · DEUniversity of Liverpool · GBRadboud University Nijmegen · NL

Funding

Biotechnology and Biological Sciences Research Council BB/I004343/1
6 · The paper itself

Abstract

introductionSulf1 and Sulf2 are cell surface sulfatases, which remove specific 6-O-sulfate groups from heparan sulfate (HS) proteoglycans, resulting in modulation of various HS-dependent signaling pathways. Both Sulf1 and Sulf2 knockout mice show impairments in brain development and neurite outgrowth deficits in neurons. METHODOLOGY AND MAIN

findingsTo analyze the molecular mechanisms behind these impairments we focused on the postnatal cerebellum, whose development is mainly characterized by proliferation, migration, and neurite outgrowth processes of precursor neurons. Primary cerebellar granule cells isolated from Sulf1 or Sulf2 deficient newborns are characterized by a reduction in neurite length and cell survival. Furthermore, Sulf1 deficiency leads to a reduced migration capacity. The observed impairments in cell survival and neurite outgrowth could be correlated to Sulf-specific interference with signaling pathways, as shown for FGF2, GDNF and NGF. In contrast, signaling of Shh, which determines the laminar organization of the cerebellar cortex, was not influenced in either Sulf1 or Sulf2 knockouts. Biochemical analysis of cerebellar HS demonstrated, for the first time in vivo, Sulf-specific changes of 6-O-, 2-O- and N-sulfation in the knockouts. Changes of a particular HS epitope were found on the surface of Sulf2-deficient cerebellar neurons. This epitope showed a restricted localization to the inner half of the external granular layer of the postnatal cerebellum, where precursor cells undergo final maturation to form synaptic contacts.

conclusionSulfs introduce dynamic changes in HS proteoglycan sulfation patterns of the postnatal cerebellum, thereby orchestrating fundamental mechanisms underlying brain development.

Indexed as

AnimalsCell MovementCells, CulturedCell SurvivalCerebellumFemaleFibroblast Growth Factor 2Glial Cell Line-Derived Neurotrophic FactorHedgehog ProteinsHeparan Sulfate ProteoglycansMaleMiceMice, Inbred C57BLMice, KnockoutNerve Growth FactorNeuritesFibroblast Growth Factor 2Glial Cell Line-Derived Neurotrophic FactorHedgehog ProteinsHeparan Sulfate ProteoglycansNerve Growth FactorShh protein, mouseSulf1 protein, mouseSulf2 protein, mouseSulfatasesSulfotransferases

Identifiers

PMID26448642
PMCPMC4598108
OpenAlexW1959500402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.